Literature DB >> 14582453

Diabetes mellitus: a cardiovascular disease.

Riccardo Candido1, Piyush Srivastava, Mark E Cooper, Louise M Burrell.   

Abstract

Cardiovascular disease (CVD) is the major cause of morbidity and mortality in patients with diabetes mellitus (DM). The pathophysiology of CVD in diabetes involves traditional and novel cardiac risk factors, including hypertension, dyslipidemia, smoking, genetic factors, hyperglycemia, insulin resistance/hyperinsulinemia, metabolic abnormalities, oxidative/glycoxidative stress, inflammation, endothelial dysfunction, a procoagulant state and myocardial fibrosis. Specific vascular, myopathic and neuropathic alterations have been suggested to be responsible for the excessive cardiovascular morbidity and mortality in diabetes. These alterations manifest themselves clinically as coronary heart disease, congestive heart failure and/or sudden cardiac death. In order to contain the emerging epidemic of CVD in DM, diabetic patients should ideally have excellent glycemic control, a low normal blood pressure and low levels of low-density lipoprotein cholesterol, and be taking an angiotensin-converting enzyme inhibitor and aspirin, which may go some way to containing the emerging epidemic of CVD in DM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582453

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  17 in total

1.  Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.

Authors:  Gideon Charach; Alexander Rabinovich; Ori Argov; Moshe Weintraub; Lior Charach; Oded Ayzenberg; Jacob George
Journal:  World J Cardiol       Date:  2012-11-26

2.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

3.  Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve.

Authors:  A Nygren; M L Olson; K Y Chen; T Emmett; G Kargacin; Y Shimoni
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

Review 4.  Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy.

Authors:  Mark T Waddingham; Amanda J Edgley; Hirotsugu Tsuchimochi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  World J Diabetes       Date:  2015-07-10

5.  Risk Factors Associated with Left Ventricular Diastolic Dysfunction in Type 2 Diabetic Patients without Hypertension.

Authors:  Jung Hyun Noh; Joon Hyung Doh; Sung Yun Lee; Tae Nyun Kim; Hyuk Lee; Hwa Young Song; Jeong Hyun Park; Kyung Soo Ko; Byoung Doo Rhee; Dong Jun Kim
Journal:  Korean Diabetes J       Date:  2010-02-28

6.  The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.

Authors:  Chaoqin Xie; Jun Hu; Lukas J Motloch; Basil S Karam; Fadi G Akar
Journal:  J Am Coll Cardiol       Date:  2015-09-08       Impact factor: 24.094

7.  Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.

Authors:  Rai Ajit K Srivastava; Ravi Jahagirdar; Salman Azhar; Somesh Sharma; Charles L Bisgaier
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

8.  Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study.

Authors:  Jorge Escobedo; Jamal S Rana; Manuel S Lombardero; Stewart G Albert; Andrew M Davis; Frank P Kennedy; Arshag D Mooradian; David G Robertson; V S Srinivas; Suzanne S P Gebhart
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

9.  Insulin and glucose play a role in foam cell formation and function.

Authors:  Pavel N Shashkin; Nitin Jain; Yury I Miller; Benjamin A Rissing; Yuqing Huo; Susanna R Keller; George E Vandenhoff; Jerry L Nadler; Thomas M McIntyre
Journal:  Cardiovasc Diabetol       Date:  2006-06-20       Impact factor: 9.951

10.  Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez; Jaime Fernández-de-Bobadilla; Xavier Frías-Garrido; Rafael Ruiz-Riera
Journal:  BMC Fam Pract       Date:  2007-10-17       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.